GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vilin Bio Med VILINBIO.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

54.55

—

Close of 5 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Vilin Bio Med — daily BSE:VILINBIO End of day BSE listing — our prices are the NSE line

Why two exchanges. Vilin Bio Med trades on both NSE and BSE. TradingView's free charts don't carry NSE, so the chart shows the BSE listing. The ticker and close we quote are the NSE line.

Market value
₹831.9m
Last close × shares
Volume
12k
Shares, 5 Nov 2026
Price to earnings
2483.3

About Vilin Bio Med

Its shares trade on NSE under the ticker VILINBIO.NS. It has been listed since 30 June 2023. In the fiscal year to 31 March 2022, it reported revenue of ₹112.1m and net income of ₹335,000. At that date it held total assets of ₹135.6m and shareholders' equity of ₹74.0m.

Vilin Bio Med Ltd is a IN-based company operating in Pharmaceuticals industry. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2023-06-30. Vilin Bio Med Limited is an India-based company. The firm is engaged in the domestic business of manufacturing pharmaceutical products. Its product categories include solid oral dosage forms (beta and non-beta-lactam), oral liquids, external preparations, and dry powders. Its products include Cefixime, Azithromycin, Sulmtmicilline, Aceclofenac, Citicolin Sodium, Metformine, Pregabaline, Gabapentin, Diclofenac Sodium, Thiocolchicoside, Linseed Oil, Menthol, and Methyl Salcilate, among others. Its external preparations offer ointments along with similar products like creams, lotions, gels, and pates in certain formulations primarily designed to be applied to the skin. Its beta-lactam products are a group of medicines that are used to treat infections caused by some germs (bacteria and certain parasites). Its non-beta-lactam tablets and capsule products are generally used for general diseases like colds, flu, fever, anti-gastrological, antimalaria, and several other viral diseases.

Figures and description from our data supplier, not checked against the company's own report.

More about Vilin Bio Med →

Latest on Vilin Bio Med

Our reporting

We have not reported on Vilin Bio Med yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Vilin Bio Med's ticker?

Vilin Bio Med trades as VILINBIO.NS on NSE, under ISIN INE0L4V01013.

What was Vilin Bio Med's last closing price?

54.55 on 5 Nov 2026. The figure is in INR and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.